References
Lee WS, Yun SH, Chun HK, Lee WY, Yun HR, Kim J, et al. Pulmonary resection for metastases from colorectal cancer: prognostic factors and survival. Int J Color Dis. 2007;22:699–704.
Van Cutsem E, Nordlinger B, Adam R, Köhne CH, Pozzo C, Poston G, et al. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer. 2006;42(14):2212–21.
Tunio MA, AlAsiri M, Riaz K, AlShakwer W, AlArifi M. Skeletal muscle metastasis secondary to adenocarcinoma of colon: a case report and review of literature. J Gastroint Dig Syst. 2013;S12:002.
Ünsal D, Üner A, Simsek A, Üzüm N, Akmansu M. Metastatic rectal adenocarcinoma to forearm muscle: an unusual site of metastasis. Turk J Cancer. 2005;35:181–5.
Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomark Prev. 2010;19:1893–907.
de Gramont A, Bosset JF, Milan C, Rougier P, Bouché O, Etienne PL, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. J Clin Oncol. 1997;15:808–15.
Van Cutsem E, Hoff PM, Harper P, Bukowski RM, Cunningham D, Dufour P, et al. Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials. Br J Cancer. 2004;90:1190–7.
Grothey A, Sargent D, Goldberg RM, Schmoll HJ. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol. 2004;22:1209–14.
Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2004;22:229–37.
Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335–42.
Van Cutsem E, Köhne CH, Láng I, Folprecht G, Nowacki MP, Cascinu S, et al. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J Clin Oncol. 2011;29:2011–9.
Patel NN, Shah PR, Wilson E, Haray PN. An unexpected supraclavicular swelling. World J Surg Oncol. 2007;5:90.
Hoehn JL, Ousley JL, Avecilla CS. Occult carcinoma of the colon and rectum manifesting as osseous metastasis. Dis Colon Rectum. 1979;22:129–32.
Ihle PM, McBeath AA. Bone metastasis from colonic carcinoma. A case report. J Bone Joint Surg Am. 1973;55:398–400.
Tsai MS, Su YH, Ho MC, Liang JT, Chen TP, Lai HS, et al. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol. 2007;14:786–94.
Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13:8–10.
Khattak MA, Martin HL, Beeke C, Price T, Carruthers S, Kim S, et al. Survival differences in patients with metastatic colorectal cancer and with single site metastatic disease at initial presentation: results from South Australian clinical registry for advanced colorectal cancer. Clin Colorectal Cancer. 2012;11:247–54.
Nakajima M, Morikawa K, Fabra A, Bucana CD, Fidler IJ. Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst. 1990;82:1890–8.
Fidler IJ, Wilmanns C, Staroselsky A, Radinsky R, Dong Z, Fan D. Modulation of tumor cell response to chemotherapy by the organ environment. Cancer Metastasis Rev. 1994;13:209–22.
Dalton WS. The tumor microenvironment as a determinant of drug response and resistance. Drug Resist Updat. 1999;2:285–8.
Tarin D. Clinical and biological implications of the tumor microenvironment. Cancer Microenviron. 2012;5:95–112.
Takada J, Watanabe K, Kuraya D, Kina M, Hayashi S, Hamada H, et al. An example of metastasis to the iliopsoas muscle from sigmoid colon cancer. Gan To Kagaku Ryoho. 2011;38(12):2294–7.
Naik VR, Jaafar H, Mutum SS. Heterotopic ossification in skeletal muscle metastasis from colonic adenocarcinoma - a case report. Malays J Pathol. 2005;27:119–21.
Burgueño Montañés C, López Roger R. Exophthalmos secondary to a lateral rectus muscle metastasis. Arch Soc Esp Oftalmol. 2002;77:507–10.
Hasegawa S, Sakurai Y, Imazu H, Matsubara T, Ochiai M, Funabiki T, et al. Metastasis to the forearm skeletal muscle from an adenocarcinoma of the colon: report of a case. Surg Today. 2000;30:1118–23.
Homan HH, Mühlberger T, Kuhnen C, Steinau HU. Intramuscular extremity metastasis of adenocarcinoma of the colon. Chirurg. 2000;71:1392–4.
Bonjer HJ, Lange JF, Jansen A, Schouten WR, Jakimowicz J, Cuesta Valentin MA, et al. Abdominal wall metastasis following surgical removal of colorectal carcinomas. Ned Tijdschr Geneeskd. 1997;141:1868–70.
Jacquet P, Averbach AM, Jacquet N. Abdominal wall metastasis and peritoneal carcinomatosis after laparoscopic-assisted colectomy for colon cancer. Eur J Surg Oncol. 1995;21:568–70.
Acknowledgements
We would like to acknowledge the Departments of Pathology, Radiology, and Nuclear Medicine at Command Hospital (SC), Pune, for their support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Singh, S., Bisht, N., Joshi, R. et al. Musculoskeletal Metastasis from Primary Rectal Cancer: Series of Two Cases of a Very Rare Occurrence with a Short Literature Review. J Gastrointest Canc 50, 991–996 (2019). https://doi.org/10.1007/s12029-018-0165-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-018-0165-5